David Roman
Stock Analyst at Goldman Sachs
(2.84)
# 1,895
Out of 5,090 analysts
57
Total ratings
45.16%
Success rate
0.24%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Upgrades: Neutral | $81 → $111 | $101.99 | +8.83% | 2 | Nov 19, 2025 | |
| IRTC iRhythm Technologies | Maintains: Neutral | $180 → $202 | $181.60 | +11.23% | 4 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $94 → $104 | $85.78 | +21.24% | 4 | Oct 31, 2025 | |
| BAX Baxter International | Maintains: Neutral | $25 → $22 | $18.48 | +19.05% | 4 | Oct 31, 2025 | |
| BBNX Beta Bionics | Maintains: Buy | $26 → $33 | $30.23 | +9.16% | 3 | Oct 29, 2025 | |
| COO The Cooper Companies | Initiates: Sell | $64 | $77.30 | -17.21% | 1 | Oct 1, 2025 | |
| BLCO Bausch + Lomb | Initiates: Neutral | $16 | $16.81 | -4.82% | 1 | Oct 1, 2025 | |
| GKOS Glaukos | Initiates: Buy | $103 | $108.85 | -5.37% | 1 | Oct 1, 2025 | |
| DOCS Doximity | Downgrades: Sell | $57 → $64 | $51.31 | +24.73% | 4 | Oct 1, 2025 | |
| SI Shoulder Innovations | Initiates: Buy | $20 | $15.12 | +32.28% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $14.21 | +33.76% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $29 | $17.51 | +65.62% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $94 → $104 | $95.43 | +8.98% | 3 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $380 | $316.45 | +20.08% | 1 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $104 | $93.16 | +11.64% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $7.78 | +28.53% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $94 → $82 | $82.46 | -0.55% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $24 → $23 | $24.35 | -5.54% | 2 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $154 | $125.40 | +22.81% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $20.65 | +16.22% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $85.26 | -16.73% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $63.67 | -13.62% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $364.35 | +17.20% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $97.72 | -7.90% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $568.65 | -12.07% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $193.76 | +41.41% | 1 | May 30, 2024 |
Medtronic
Nov 19, 2025
Upgrades: Neutral
Price Target: $81 → $111
Current: $101.99
Upside: +8.83%
iRhythm Technologies
Oct 31, 2025
Maintains: Neutral
Price Target: $180 → $202
Current: $181.60
Upside: +11.23%
Edwards Lifesciences
Oct 31, 2025
Maintains: Buy
Price Target: $94 → $104
Current: $85.78
Upside: +21.24%
Baxter International
Oct 31, 2025
Maintains: Neutral
Price Target: $25 → $22
Current: $18.48
Upside: +19.05%
Beta Bionics
Oct 29, 2025
Maintains: Buy
Price Target: $26 → $33
Current: $30.23
Upside: +9.16%
The Cooper Companies
Oct 1, 2025
Initiates: Sell
Price Target: $64
Current: $77.30
Upside: -17.21%
Bausch + Lomb
Oct 1, 2025
Initiates: Neutral
Price Target: $16
Current: $16.81
Upside: -4.82%
Glaukos
Oct 1, 2025
Initiates: Buy
Price Target: $103
Current: $108.85
Upside: -5.37%
Doximity
Oct 1, 2025
Downgrades: Sell
Price Target: $57 → $64
Current: $51.31
Upside: +24.73%
Shoulder Innovations
Aug 25, 2025
Initiates: Buy
Price Target: $20
Current: $15.12
Upside: +32.28%
Aug 18, 2025
Initiates: Buy
Price Target: $19
Current: $14.21
Upside: +33.76%
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $17.51
Upside: +65.62%
Jun 4, 2025
Maintains: Neutral
Price Target: $94 → $104
Current: $95.43
Upside: +8.98%
May 30, 2025
Initiates: Buy
Price Target: $380
Current: $316.45
Upside: +20.08%
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $93.16
Upside: +11.64%
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $7.78
Upside: +28.53%
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $82.46
Upside: -0.55%
Apr 16, 2025
Maintains: Neutral
Price Target: $24 → $23
Current: $24.35
Upside: -5.54%
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $125.40
Upside: +22.81%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $20.65
Upside: +16.22%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $85.26
Upside: -16.73%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $63.67
Upside: -13.62%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $364.35
Upside: +17.20%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $97.72
Upside: -7.90%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $568.65
Upside: -12.07%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $193.76
Upside: +41.41%